← Back to headlines
BioCardia Outlines Japan Shonin Filing and Approval Timeline for CardiAMP
BioCardia has provided an update on its regulatory strategy for CardiAMP in Japan, indicating a Shonin filing within approximately seven months and targeting an approval pathway of around 19 months.
15 May, 22:21 — 15 May, 22:21
Sources
Showing 1 of 1 sources
